← Evidence map

ArticleThe American journal of pathology2011

Survivin is a novel target of CD44-promoted breast tumor invasion.

Mohamed E Abdraboh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

23 papers cite it

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 21718681